Target intelligence / Profile preview

Tetraspanin-12 (TSPAN12)

Target
TSPAN12
Molecular classification
Tetraspanin family, Transmembrane protein, Cell membrane protein (four-transmembrane domain)
01

Overview

Tetraspanin-12 (TSPAN12) is a member of the tetraspanin family, which are membrane proteins characterized by four transmembrane domains. TSPAN12 is expressed widely across tissues and is notable for its unusually long cytoplasmic C-terminal tail. It forms part of tetraspanin-enriched microdomains (TEMs) on cell membranes, mediating the assembly and function of protein complexes involved in diverse cellular processes. Functionally, TSPAN12 is a crucial modulator of ADAM10, a membrane protease essential for the cleavage of amyloid precursor protein (APP)—a process implicated in Alzheimer’s disease. Additionally, TSPAN12 acts as a co-receptor in the Norrin–Frizzled-4/LRP5 pathway, playing an indispensable role in retinal vascular development and homeostasis. Pathogenic variants in TSPAN12 are strongly associated with familial exudative vitreoretinopathy. Overexpression or altered function of TSPAN12 has been implicated in cancer progression by protecting β-catenin from degradation and influencing cell adhesion molecules

Other names
Tetraspanin-12NET2TM4SF12Tspan-12NET-2Transmembrane 4 superfamily member 12EVR5UNQ774/PRO1568tetraspan NET-2
02

Mechanism of action

Enhancers or inhibitors of Tetraspanin-12–ADAM10 interaction may modulate APP cleavage (therapeutic relevance for Alzheimer’s disease). Disruption/modulation of TSPAN12–Norrin/Frizzled-4/LRP5 signaling may influence vascular or retinal pathophysiology.

03

Biological functions

Regulation of membrane protein maturation (notably ADAM10)Modulation of proteolysis of amyloid precursor protein (APP)Promotion of Norrin–Frizzled-4/LRP5/β-catenin signaling in vascular and retinal developmentRegulation of cell adhesion molecule functionCell signaling within tetraspanin-enriched microdomains
04

Disease associations

Cancer (primary and metastatic)Congenital retinal vascular disorders (e.g., familial exudative vitreoretinopathy/FEVR)Alzheimer's disease (via amyloid precursor protein processing)
05

Safety considerations

Potential off-target effects on nervous system or vascular development due to broad tissue expression and central role in developmental and signaling pathways
06

Biomarkers

TSPAN12 genetic variants used as biomarker for familial exudative vitreoretinopathy (FEVR) and retinal vascular anomalies

Beyond the preview

Go deeper on Tetraspanin-12 (TSPAN12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetraspanin-12 (TSPAN12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call